← SearchEVALUATION OF THE SAFETY AND EFFICACY OF NE3107, A SAFE, ORALLY BIOAVAILABLE, BLOOD-BRAIN BARRIER-PERMEABLE ANTI-INFLAMMATORY AND INSULIN-SENSITIZING AGENT FOR TREATMENT OF LONG COVID$499,200FY2025Defense Health AgencyDODBiovie IncInvestigatorsView source on USAspending →